sergiod
Long

ETRM potential inverse H&S

NASDAQ:ETRM   ENTEROMEDICS INC
125 0 0
After FDA approval ETRM             had unexpected correction due to challenges and associated costs to develop and market the new device. If price recovers soon and stays above 1.45, we may see a upside trend with 1.9 target following the development of the potential H&S pattern.
English
English (UK)
English (IN)
Deutsch
Français
Español
Italiano
Polski
Türkçe
Русский
Português
Bahasa Indonesia
Bahasa Melayu
ภาษาไทย
Tiếng Việt
日本語
한국어
简体
台灣
Home Stock Screener Forex Signal Finder Cryptocurrency Signal Finder Economic Calendar How It Works Chart Features House Rules Moderators Website & Broker Solutions Widgets Stock Charting Library Feature Request Blog & News FAQ Help & Wiki Twitter
Profile Profile Settings Account and Billing My Support Tickets Contact Support Ideas Published Followers Following Private Messages Chat Sign Out